NCT03700099 2024-04-15Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by EnzalutamideInstituto do Cancer do Estado de São PauloPhase 2 Unknown30 enrolled